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ABSTRACT 
 
Hemophagocytic syndrome , also known as hemophagocytic lymphohistiocytosis (HLH) is the manifestation of 
immune dysregulation. It is associated with ineffective but increased response and infiltration of active lymphocytes 
and histiocytes in various organs. It presents with clinical and biochemical manifestations of fever, splenomegaly, 
pancytopenia, hypertriglyceridemia, hyperferrritinemia. It can be primary or secondary. Primary (genetic) usually 
presents in childhood. Secondary is due to infection by viruses or other etiologies are also important as early 
detection and treatment improves the survival rate in this devastating disease. Hemophagocytosis due to tuberculosis 
is uncommon. Few cases have been reported in literature. The present case report is of a 20 year male, diagnosed as 
secondary HLH due to tuberculosis, highlighting importance of early diagnosis and treatment of this devastating 
disease, thus reducing the mortality.    
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Introduction 
 
Hemophagocytic lymphohistiocytosis /Hemo-
phagocytic syndrome is an immune dysregulation 
syndrome, associated with ineffective but exaggerated 
immune response and infiltration of active 
lymphocytes and histiocytes in various organs. It was 
first described in 1952 by the Scottish paediatricians  
James Farquhar and Albert Clarieaux, who encountered 
2 infants with an unrecognized complex of cytopenias, 
hepatosplenomegaly and unremitting fevers. Both 
infants died a few weeks after initial presentation. 
Upon autopsy, there was evidence of widespread 
infiltration in the lymph nodes, spleen, liver and bone 
marrow with lypmhocytes and benign appearing 
histiocytes with hemophagocytosis. They identified 
this syndrome as familial hemophagocyticreticulosis 
[1] which is now known as HLH. Its incidence is 1.2 
_______________________________ 
*Correspondence  
Dr. N Rastogi 
Department of Pathology, Government Medical 
College, Kota, Rajasthan, India 
E Mail: nupurkota123@gmail.com 
 
 
cases per 1,000,000 individuals per year [2]. 
It is characterized by clinical and biochemical 
manifestations of fever, cytopenias, splenomegaly, 
hypofibrinogenemia and or hypertriglyceridemia, 
hemophagocytosis in bone marrow/ spleen/ lymph 
nodes, ferrrrtin> 500 ug/L, soluble CD 25> 2400 U/L 
and low natural killer cell activity, 5 out of these 8 
criteria are required for the diagnosis. It can be either 
primary or secondary. Primary HLH usually presents in 
childhood. Secondary HLH occurs due to infection 
with Epstein bar virus, tuberculosis, malaria, 
rheumatological disorders, malignancy [3-5]. 
Hemophagocytosis due to tuberculosis is very rare 
[3,4]. Very few cases have been reported mostly in 
immunocompromised patients. We report a case of 
hemophagocytic syndrome secondary to tuberculosis in 
immunocompetent man. Early diagnosis and treatment 
is a demanding need in this devastating disease.  
 
Case report 
 
A 20 year old male presented with high grade fever of 
2-3 months duration, ascites and cervical 
lymphadenopathy. Patient did not respond to treatment 
for fever. He was subjected to cytology OPD for 
FNAC of cervical lymph node. Cytosmears from 
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cervical lymph node showed predominantly 
caseousnecroisis and few lymphocytes. Epithelioid 
granuloma were not seen on cytosmears , (Fig 1). On 
further investigations, S. Ferritin level was raised upto 
736 ug/L ( N-24-336 ug/L in males) ,  S. LDH level -
4000 IU/L (N- 105-333 IU/L) . Liver enzymes were 
raised, SGOT – 52 IU/L, SGPT- 72 IU/L, renal 
function and other biochemistry investigations were 
within normal range. USG abdomen showed mild 
splenomegaly, hepatomegaly, multiple lymph nodes 
measuring upto 1.5 cm. Ascitic fluid was tapped which 
showed raised ADA level upto 85 U/L. Chest X-Ray 
was unremarkable.  
Further, Bone Marrow Aspiration was done which 
showed hypercellular marrow with normoblastic and 
megaloblastic hyperplasia. Significant increase in 
number of macrophages was seen with significant high 
hemophagocytic activity (Fig2,3). Later, biopsy of 
cervical lymph node was done which showed 
epithelioid granulomas. Hemophagocytic activity was 
not seen in the lymph node (Fig 4). Hence, considering 
all the investigation parameters, a diagnosis of 
Hemophagocytic lymphohistiocytosis (HLH) 
secondary to tuberculosis was made. Patient was put on 
antitubercular drugs and steroids. He responded well to 
the treatment within 7 days.  
 
 
 
Fig 1:Cytosmears showing necrosis in cervical lymph    Fig 2:Hemopahgocytosis in bone marrow, MGG 
node, MGG stain, 40 X                                                             stain, 40 X 
 
 
Fig 3:Hemophagocytosis in bone marrow Fig 4:Epithelioid granulomas in Lymph node  
 MGG stain, 40 X                                                              biopsy,H&E stain, 40 X 
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Discussion 
 
Hemophagocytic syndrome / Hemophagocytic 
lymphohistiocytosis (HLH) is a disorder characterized 
by benign proliferation of the mature histiocytes and 
phagocytosis of the platelet,  erythrocytes, lymphocytes 
and their hematopoetic precursors in the Bone Marrow 
giving rise to cytopenias [5-8].  
Many patients present with fever of unknown origin 
[9]. The onset of systemic manifestations is abrupt, like 
pallor, fever, rash, lymphadenopathy, 
hepatosplenomegaly, neurological manifestations, 
raised lactate dehydrogenase (LDH) and serum 
bilirubin. It may take fulminant course with fatal 
outcome [6,7].  
 
Hemophagocytic syndrome is a life threatening 
immune dysregulatory syndrome caused by severe 
hypercytokinemia due to stimulated but ineffective 
immune process. Clinical manifestations of HLH are 
due to hyperactivation of CD8+ T lymphocytes and 
macrophages, proliferation, ectopic migration and 
infiltration of these cells into various organs, 
hypercytokinemia with persistently elevated levels of 
multiple proinflammatory cytokines resulting in 
progressive organ dysfunction that may lead to death 
[3].  
These interrelated factors are responsible for clinical 
manifestations of prolonged fever, 
hepatosplenomegaly, bleeding, skin rash, CNS 
abnormalities, jaundice and laboratory findings of 
bicytopenia or pancytopenia, coagulopathy, 
hyperlipidemia, hypofirinogenemia, hyperferritinemia , 
transaminitis, hyperbilirubinemia and 
hypoalbuminemia [10]. 
 Main causes of mortality are central nervous system 
dysfunction, multiorgan failure, and disseminated 
bacterial or fungal infections due to 
prolongedneutropenia[11-13]. HLH can be primary 
(familial ) and secondary. 
 Primary HLH usually present in childhood particularly 
< 2 years of age [14], associated with perforin 
mutation. Secondary HLH is associated with 
production of high levels of activating cytokines by 
host lymphocytes and monocytes. It occurs due to 
infection (Epstein bar virus, parvovirus, varicella 
zoster, HIV, mycobacterial, fungal, leishmaniasis, 
leptospirosis, rickettsia, toxoplasmosis, malaria, etc), 
auto-immune or auto-inflammatory diseases, systemic 
lupus erythematosus, rheumatoid arthritis, Sjogren’s 
and Systemic Juvenile idiopathic arthritis, 
malignancies or iatrogenic immunosuppression [4].  
 
To diagnose HLH 5 out of 8 of the criteria set up by 
Histiocytic Society 2004 must be present[15], table 1. 
 
 
Table 1:  Diagnostic criteria for hemophagocytic lymphohistiocytosis. According to the HLH 2004 Protocol 
 
A diagnosis of HLH can be made if either criteria 1 or 2 is met: 
1. Molecular diagnosis consistent with HLH 
2. Clinical and laboratory criteria (at least 5/8 criteria should be fulfilled) 
- Fever 
- Splenomegaly 
- Cytopenia> 2-3 cell lines in peripheral blood 
-  (hemoglobin < 9 g/100 ml, platelets < 100x 10 /L,Neutrophils< 1.0 x 10 /L 
- Hypertriglyceridemia and/or hypofibrinogenemia (fasting triglycerides > 3.0 mmol/L, fibrinogen < 1.5 g/L) 
- Hemophagocytosis in bone marrow, spleen, CSF, or lymph nodes. No sign of malignancy 
- Decreased or absent NK-cell activity (according to local laboratory reference) 
- Ferritin > 500 ug/L 
- sCD25 (soluble IL-2 receptor) > 2,400 U/ml 
Supportive evidence includes: 
Cerebral symptoms with moderate pleocytosis and/or 
Elevated protein 
Elevated transaminases 
Elevated bilirubin 
Elevated LDH 
 
Our patient fulfilled 5 out of 8 criteria as he had fever, 
splenomegaly, pancytopenia, bone marrow evidence of 
hemophagocytosis, hyperferritinemia. Bone marrow 
aspiration has a sensitivity of 84 % for the diagnosis of 
HLH. Most studies require a number of macrophage 
showing signs of phagocytic activity above 2-3 % and 
a median of 6 histiocytes per 500 nucleated cells [17]. 
Hemophagocytosis due to tuberculosis is unusual. 
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There are only few cases reported. HLH due to 
tuberculosis has high mortality rate (50%). Most of 
case report reveals death of the patient [16]. Judicious 
case detection and timely management have important 
prognostic significance. Poor prognostic markers are 
age over 30 years, high ferritin, delay in treatment, 
disseminated intravascular coagulation, etc. 
 
Conclusion 
 
Tuberculosis, is a common disease in India, with varied 
manifestations. It can also present as HLH. Prompt 
diagnosis and early initiation of treatment can reduce 
the high mortality associated with this disease. 
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